Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1985 3
1986 3
1987 6
1988 3
1989 6
1990 3
1991 5
1992 1
1993 6
1994 6
1995 5
1996 8
1997 8
1998 6
1999 6
2000 8
2001 10
2002 13
2003 21
2004 27
2005 28
2006 35
2007 39
2008 54
2009 84
2010 79
2011 90
2012 104
2013 130
2014 160
2015 172
2016 181
2017 193
2018 223
2019 250
2020 307
2021 353
2022 463
2023 434
2024 534
2025 619
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,231 results

Results by year

Filters applied: . Clear all
Page 1
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis.
Wang X, Zhang Y, Jin Y, Dai L, Yue Y, Hu J, Liu X, Pang K, Ye S, Chen Y, Ye W, Shi X, Ma X, Guo L, Liu Y, Ta N, Zhu X, Lin L, Wang J, Yan R, Wang P, Song X, Zhou Y, Zhou L, Wang Q, Guan T, Li T, Zhou L, Pan W, He Y, Wu X, Xu Y, Yang L, Xu H. Wang X, et al. Among authors: yan r. Cell. 2025 Aug 7;188(16):4225-4238.e12. doi: 10.1016/j.cell.2025.05.038. Epub 2025 Jun 24. Cell. 2025. PMID: 40562027
Neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma.
An X, Guo SJ, Yan R, Xue T, Xiong LB, Ma HL, Xue C, Zhang YC, Li JB, Chen MT, Li ZS, Liu TY, Zhang ZL, Dong P, Li YH, Yao K, Hu ZQ, Chen XF, Luo JX, Lei YH, Liang PY, Liu ZZ, Qi L, Xu WF, Cao ZG, Chen NH, Li X, Sheng XN, Luo GH, Shi BK, Xie Q, Liu ZW, Zhou FJ, Spiess PE, Shi YX, Han H. An X, et al. Among authors: yan r. Cancer Cell. 2025 May 12;43(5):970-980.e3. doi: 10.1016/j.ccell.2025.03.023. Epub 2025 Apr 10. Cancer Cell. 2025. PMID: 40215977 Free article. Clinical Trial.
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.
Wang X, Zhang Y, Wang H, Wu X, He C, Lin S, Pang K, Li Y, Chen Y, Tang X, Liu X, Wang J, Ye S, Yan R, Guan T, Dai B, Lu J, He H, Lin L, Lu H, Li T, Zhou L, Ye L, Zhao J, Liu Y, Ta N, Wu J, Cai W, Wan Z, Zhang S, Sun R, Zhao X, Wang J, Lin Y, Ning B, Zhao Z, Tang X, Du J, Mao Z, He Y, Zheng H, Sun L, Lin X, Xu H. Wang X, et al. Among authors: yan r. Nat Med. 2025 Nov;31(11):3713-3724. doi: 10.1038/s41591-025-03899-x. Epub 2025 Aug 27. Nat Med. 2025. PMID: 40866583 Clinical Trial.
4,231 results